<topic id="PHP1494" outputclass="drug">
  <title>WARFARIN SODIUM</title>
  <body>
    <p outputclass="interactionsLinks"> List of individual interactants: <xref format="dita" href="bnf_int_222.xml">Warfarin</xref>, <xref format="dita" href="bnf_int_222.xml">Warfarin</xref></p>
    <data name="vtmid">48603004</data>
    <data name="classifications">
      <data name="classification">
        <data name="drugClassification">PHP106980:454</data>
        <data name="inheritsFromClass">PHP34518</data>
      </data>
      <data name="classification">
        <data name="drugClassification">PHP106980:454</data>
        <data name="inheritsFromClass">PHP34518</data>
      </data>
    </data>
    <data name="primaryDomainOfEffect">
      <data name="domainOfEffect"> cardiovascular system <data name="primaryTherapeuticUse"><data name="therapeuticUse"> blood clots <data name="therapeuticUse"> thromboembolism </data></data></data></data>
    </data>
  </body>
  <topic id="PHP57389" outputclass="indicationsAndDose">
    <title>Indications and dose</title>
    <body>
      <section outputclass="indicationAndDoseGroup">
        <sectiondiv outputclass="therapeuticIndications">
          <p outputclass="therapeuticIndication">Prophylaxis of embolisation in rheumatic heart disease and atrial fibrillation</p>
          <p outputclass="therapeuticIndication">Prophylaxis after insertion of prosthetic heart valve</p>
          <p outputclass="therapeuticIndication">Prophylaxis and treatment of venous thrombosis and pulmonary embolism</p>
          <p outputclass="therapeuticIndication">Transient ischaemic attacks</p>
        </sectiondiv>
        <p outputclass="routesOfAdministration">By mouth</p>
        <ul outputclass="patientGroups">
          <li outputclass="patientGroup adult">
            <p>Adult</p>
            <p>Initially 5–10 mg, to be taken on day 1; subsequent doses dependent on the prothrombin time, reported as INR (international normalised ratio), a lower induction dose can be given over 3–4 weeks in patients who do not require rapid anticoagulation, elderly patients to be given a lower induction dose; maintenance 3–9 mg daily, to be taken at the same time each day.</p>
          </li>
          <li outputclass="patientGroup adult">
            <p>Adult</p>
            <p>Initially 5–10 mg, to be taken on day 1; subsequent doses dependent on the prothrombin time, reported as INR (international normalised ratio), a lower induction dose can be given over 3–4 weeks in patients who do not require rapid anticoagulation, elderly patients to be given a lower induction dose; maintenance 3–9 mg daily, to be taken at the same time each day.</p>
          </li>
        </ul>
         <p outputclass="routesOfAdministration">By mouth</p>
        <ul outputclass="patientGroups">
          <li outputclass="patientGroup adult">
            <p>Adult</p>
            <p>Initially 5–10 mg, to be taken on day 1; subsequent doses dependent on the prothrombin time, reported as INR (international normalised ratio), a lower induction dose can be given over 3–4 weeks in patients who do not require rapid anticoagulation, elderly patients to be given a lower induction dose; maintenance 3–9 mg daily, to be taken at the same time each day.</p>
          </li>
        </ul>
      </section>
    </body>
  </topic>
  <topic id="PHP57343" outputclass="pregnancy">
    <title>Pregnancy</title>
    <body>
      <section outputclass="generalInformation">
        <sectiondiv>
          <p>Babies of mothers taking warfarin at the time of delivery need to be offered immediate prophylaxis with intramuscular phytomenadione (vitamin K<sub>1</sub>).</p>
          <p>Babies of mothers taking warfarin at the time of delivery need to be offered immediate prophylaxis with intramuscular phytomenadione (vitamin K<sub>1</sub>).</p>
        </sectiondiv>
      </section>
    </body>
  </topic>
  <topic id="PHP57637" outputclass="breastFeeding">
    <title>Breast feeding</title>
    <body>
      <section outputclass="generalInformation">
        <sectiondiv>
          <p>Not present in milk in significant amounts and appears safe.</p>
          <p>Risk of haemorrhage which is increased by vitamin K deficiency.</p>
        </sectiondiv>
      </section>
    </body>
  </topic>
  <topic id="PHP57498" outputclass="hepaticImpairment">
    <title>Hepatic impairment</title>
    <body>
      <section outputclass="generalInformation">
        <sectiondiv>
          <p>Avoid in severe impairment, especially if prothrombin time is already prolonged.</p>
          <p>Avoid in severe impairment, especially if prothrombin time is already prolonged.</p>
        </sectiondiv>
      </section>
    </body>
  </topic>
  <topic id="PHP57319" outputclass="renalImpairment">
    <title>Renal impairment</title>
    <body>
      <section outputclass="generalInformation">
        <sectiondiv>
          <p>Use with caution in mild to moderate impairment.</p>
          <p>Use with caution in mild to moderate impairment.</p>
        </sectiondiv>
      </section>
      <section outputclass="additionalMonitoringInRenalImpairment">
        <sectiondiv>
          <p>In severe renal impairment, monitor INR more frequently.</p>
          <p>In severe renal impairment, monitor INR more frequently.</p>
        </sectiondiv>
      </section>
    </body>
  </topic>
  <topic id="PHP57334" outputclass="patientAndCarerAdvice">
    <title>Patient and carer advice</title>
    <body>
      <section outputclass="patientResources">
        <sectiondiv>
          <p>Anticoagulant card to be provided.</p>
          <p>Anticoagulant card to be provided.</p>
        </sectiondiv>
      </section>
    </body>
  </topic>
  <topic id="PHP1494-medicinalForms" outputclass="medicinalForms">
    <title>Medicinal forms</title>
    <body>
      <section outputclass="licensingVariationStatement">
        <p>There can be variation in the licensing of different medicines containing the same drug.</p>
      </section>
      <p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>
    </body>
    <xref href="PHP77354.xml" rel="medicinalForm">Tablet</xref>
    <xref href="PHP77347.xml" rel="medicinalForm">Oral suspension</xref>
  </topic>
</topic>
